Product Information

CARVEDILOL 6.25 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.0176 per EA under NDC 68084085401. Its NADAC has been published 597 times since Jun 10, 2015.

FDA first approved this application on Sep 5, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Carvedilol market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CARVEDILOL 6.25 MG TABLET

Carvedilol
$0.0176per EA
Low Outlier

Strength

6.25 mg/1

NDC

68084085401

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

CARVEDILOL

Approval Type

Generic (ANDA)

FDA Application

ANDA077614

FDA Approved

9/5/2007

TE Code

AB

On Market Since

5/4/2015

Pharmacological Classes

Adrenergic alpha-Antagonists
Adrenergic beta1-Antagonists
Adrenergic beta2-Antagonists
alpha-Adrenergic Blocker
beta-Adrenergic Blocker

Price Statistics

The NADAC for CARVEDILOL 6.25 MG TABLET has been published 597 times since Jun 10, 2015, and over the history we have for it it has declined 41.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0176 per EA
All-time high$0.0350 (Jan 13, 2016)
All-time low$0.0155 (Nov 20, 2024)
52-week high$0.0187
52-week low$0.0176
Median price$0.0232
Average price$0.0230
Largest weekly change-21.2% (Nov 20, 2024)
Weeks tracked597
Tracking sinceJun 10, 2015

Price History

1W

0.0%

1M

-1.8%

3M

-4.2%

6M

-4.7%

1Y

-4.7%

3Y

-10.5%

5Y

-23.0%

All

-41.7%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CARVEDILOL 6.25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL 6.25 MG TABLET, manufactured by American Health Packaging, is $0.0176 per EA (NDC 68084085401), effective Nov 11, 2026.

How has the price of CARVEDILOL 6.25 MG TABLET changed over time?

Over the history we have for it, the NADAC for CARVEDILOL 6.25 MG TABLET has declined 41.7%. It has been tracked across 597 weekly CMS publications since Jun 10, 2015.

What are the highest and lowest recorded NADAC prices for CARVEDILOL 6.25 MG TABLET?

Since Jun 10, 2015, the NADAC for CARVEDILOL 6.25 MG TABLET has ranged from a low of $0.0155 (Nov 20, 2024) to a high of $0.0350 (Jan 13, 2016), with a median of $0.0232 per EA.

Are there cheaper alternatives to CARVEDILOL 6.25 MG TABLET?

10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CARVEDILOL 6.25 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CARVEDILOL 6.25 MG TABLET?

CARVEDILOL 6.25 MG TABLET (NDC 68084085401) is labeled by American Health Packaging, and CMS classifies it as a generic product.